SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Boris D. Zlatopolskiy, Johannes Zischler, Elizaveta A. Urusova, Heike Endepols, Elena Kordys, Holm Frauendorf, Felix M. Mottaghy, Bernd Neumaier, A Practical One-Pot Synthesis of Positron Emission Tomography (PET) Tracers via Nickel-Mediated Radiofluorination, ChemistryOpen, 2015, 4, 3
  2. 2
    Rajesh Narendran, Hank P. Jedema, Brian J. Lopresti, Neale Scott Mason, Michael L. Himes, Charles W. Bradberry, Decreased Vesicular Monoamine Transporter Type 2 Availability in the Striatum Following Chronic Cocaine Self-Administration in Nonhuman Primates, Biological Psychiatry, 2015, 77, 5, 488

    CrossRef

  3. 3
    Y. Furukawa, S. J. Kish, Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia, Brain, 2015, 138, 5, e351

    CrossRef

  4. 4
    Wataru Sako, Aziz M. Uluğ, David Eidelberg, Movement Disorders, 2015,

    CrossRef

  5. 5
    Stephen J. Kish, The Effects of Drug Abuse on the Human Nervous System, 2014,

    CrossRef

  6. 6
    Andre C. Felicio, A. Jon Stoessl, Imaging of the Human Brain in Health and Disease, 2014,

    CrossRef

  7. 7
    Pankaj A. Agarwal, A. Jon Stoessl, Biomarkers for trials of neuroprotection in Parkinson's disease, Movement Disorders, 2013, 28, 1
  8. 8
    P. E. Harris, R. L. Leibel, Neurofunctional imaging of β-cell dynamics, Diabetes, Obesity and Metabolism, 2012, 14,
  9. 9
    André R. Troiano, Handbook of Dystonia, 2012,

    CrossRef

  10. 10
    A Jon Stoessl, WR Wayne Martin, Martin J McKeown, Vesna Sossi, Advances in imaging in Parkinson's disease, The Lancet Neurology, 2011, 10, 11, 987

    CrossRef

  11. 11
    Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L. Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi, Thomas J. Ruth, Chong S. Lee, Donald B. Calne, A. Jon Stoessl, Age-specific progression of nigrostriatal dysfunction in Parkinson's disease, Annals of Neurology, 2011, 69, 5
  12. 12
    Raúl de la Fuente-Fernández, Silke Appel-Cresswell, Doris J Doudet, Vesna Sossi, Functional neuroimaging in Parkinson's disease, Expert Opinion on Medical Diagnostics, 2011, 5, 2, 109

    CrossRef

  13. 13
    A. Jon Stoessl, David J. Brooks, David Eidelberg, Milestones in neuroimaging, Movement Disorders, 2011, 26, 6
  14. 14
    A. Jon Stoessl, Neuroimaging in Parkinson’s Disease, Neurotherapeutics, 2011, 8, 1, 72

    CrossRef

  15. 15
    Valentina Berti, Alberto Pupi, Lisa Mosconi, PET/CT in diagnosis of movement disorders, Annals of the New York Academy of Sciences, 2011, 1228, 1
  16. 16
    Michael R. Kilbourn, Elizabeth R. Butch, Timothy Desmond, Phillip Sherman, Paul E. Harris, Kirk A. Frey, In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations, Nuclear Medicine and Biology, 2010, 37, 1, 3

    CrossRef

  17. 17
    Isabelle Boileau, Sylvain Houle, Pablo M. Rusjan, Yoshiaki Furukawa, Diana Wilkins, Junchao Tong, Peter Selby, Alan A. Wilson, Stephen J. Kish, Influence of a low dose of amphetamine on vesicular monoamine transporter binding: A PET (+)[11C]DTBZ study in humans, Synapse, 2010, 64, 6
  18. 18
    Vesna Sossi, Katherine Dinelle, Michael Schulzer, Edwin Mak, Doris J. Doudet, Raúl de la Fuente-Fernández, Levodopa and pramipexole effects on presynaptic dopamine PET markers and estimated dopamine release, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 12, 2364

    CrossRef

  19. 19
    G. Biju, R. de la Fuente-Fernández, Dopaminergic function and progression of Parkinson's disease: PET findings, Parkinsonism & Related Disorders, 2009, 15, S38

    CrossRef

  20. 20
    Raúl de la Fuente-Fernández, Vesna Sossi, Siobhan McCormick, Michael Schulzer, Thomas J. Ruth, A. Jon Stoessl, Visualizing vesicular dopamine dynamics in Parkinson's disease, Synapse, 2009, 63, 8
  21. 21
    Michael R. Kilbourn, E.R. Butch, T. Desmond, P. Sherman, K.A. Frey, Dopamine depletion increases in vivo [11C]DTBZ binding in awake rat brain, NeuroImage, 2008, 41, T54

    CrossRef

  22. 22
    Junchao Tong, Alan A. Wilson, Isabelle Boileau, Sylvain Houle, Stephen J. Kish, Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration, Synapse, 2008, 62, 11
  23. 23
    G. Quincoces, M. Collantes, R. Catalán, M. Ecay, E. Prieto, E. Martino, F.J. Blesa, L. Álvarez-Erviti, P. Areses, J. Arbizu, J.Á. Obeso, J.M. Martí-Climent, J.Á. Richter, I. Peñuelas, Quick and simple synthesis of 11C-(+)-α-dihydrotetrabenazine to be used as a PET radioligand of vesicular monoamine transporters, Revista Española de Medicina Nuclear (English Edition), 2008, 27, 1, 13

    CrossRef

  24. 24
    G. Quincoces, M. Collantes, R. Catalán, M. Ecay, E. Prieto, E. Martino, F.J. Blesa, L. Álvarez-Erviti, P. Areses, J. Arbizu, J.Á. Obeso, J.M. Martí-Climent, J.Á. Richter, I. Peñuelas, Síntesis rápida y simplificada de 11C-(+)-α-dihidrotetrabenazina para su utilización como radioligando PET de los transportadores vesiculares de monoaminas, Revista Española de Medicina Nuclear, 2008, 27, 1, 13

    CrossRef

  25. 25
    M. Collantes, I. Peñuelas, L. Álvarez-Erviti, J. Blesa, J.M. Martí-Climent, G. Quincoces, M. Delgado, M. Ecay, A. Martínez, J. Arbizu, M.C. Rodríguez-Oroz, J. Obeso, J.Á. Richter, Use of 11C-(+)-α-dihydrotetrabenazine for the assessment of dopaminergic innervation in animal models of Parkinson's disease, Revista Española de Medicina Nuclear (English Edition), 2008, 27, 2, 103

    CrossRef

  26. 26
    M. Collantes, I. Peñuelas, L. Álvarez-Erviti, J. Blesa, J.M. Martí-Climent, G. Quincoces, M. Delgado, M. Ecay, A. Martínez, J. Arbizu, M.C. Rodríguez-Oroz, J. Obeso, J.Á. Richter, Utilización de la 11C-(+)-α-dihidrotetrabenazina para la evaluación de la inervación dopaminérgica en modelos animales de la enfermedad de Parkinson, Revista Española de Medicina Nuclear, 2008, 27, 2, 103

    CrossRef

  27. 27
    Rajan Murthy, Paul Harris, Norman Simpson, Ronald Van Heertum, Rudolph Leibel, J. John Mann, Ramin Parsey, Whole body [11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates, European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35, 4, 790

    CrossRef

  28. 28
    Dima A. Hammoud, John M. Hoffman, Martin G. Pomper, Molecular Neuroimaging: From Conventional to Emerging Techniques1, Radiology, 2007, 245, 1, 21

    CrossRef

  29. 29
    Michael R. Kilbourn, Brian Hockley, Lihsueh Lee, Catherine Hou, Rajesh Goswami, Datta E. Ponde, Mei-Ping Kung, Hank F. Kung, Pharmacokinetics of [18F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain, Nuclear Medicine and Biology, 2007, 34, 3, 233

    CrossRef

  30. 30
    Nicolaas I Bohnen, Roger L Albin, Robert A Koeppe, Kristine A Wernette, Michael R Kilbourn, Satoshi Minoshima, Kirk A Frey, Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease, Journal of Cerebral Blood Flow & Metabolism, 2006,

    CrossRef

  31. 31
    A. R. Troiano, A. J. Stoessl, Handbook of Dystonia, 2006,

    CrossRef

  32. 32
    S. Thobois, M. Jahanshahi, S. Pinto, R. Frackowiak, P. Limousin-Dowsey, PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences, NeuroImage, 2004, 23, 1, 1

    CrossRef

  33. 33
    Stephen M. Moerlein, Zhude Tu, PET IMAGING OF THE PHARMACOKINETICS OF SMALL MOLECULAR-WEIGHT DRUGS,